Epitracker

Epitracker, Inc. is unlocking secrets long held by dolphins to help treat the world’s most devastating diseases. Combining metabolomics and big data analytics, Epitracker has discovered over one hundred smart-screened small molecules targeting aging associated diseases. Our lead compound, ETI-101, has demonstrated broad efficacy in alleviating inflammation, anemia, fibrosis and metabolic syndrome. Epitracker is currently building strategic partnerships with VCs and industry to advance ETI-101 and additional compounds for anti-aging, skin repair, and Alzheimer’s disease.

Epitracker in the News